Investors are often intrigued with small-cap biotechnology stocks because of the potential for astronomical returns. At the same time, however, the risks can be deadly to one's portfolio. So before investing in these types of companies, investors must be sure to understand the entire operation including the pipeline, the fundamentals, and the science. After examining all of these critical components, one stock that appears to have a lot of potential is Threshold Pharmaceuticals (THLD).
Threshold Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery, development, and commercialization of cancer therapeutics based on targeting tumor hypoxia. The goal is for the company to be able to expand its platform to treat a variety of different...
Only subscribers can access this article, which is part of the PRO research library covering 3,589 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: